Guangzhou Innocare Pharma Tech Co., Ltd.
USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Guangzhou ranks #47,250 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 3 technology areas.
- #47,250
- of 49,997 US assignees by volume
- 26th percentile
- by Innovation Score (28.2/100)
- 9.8
- avg claims per patent
- +300%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R47250 · Foreign Corporation #47,250 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #47,250/49,997
- PHOTO-FINISH Guangdong Midea…
- CPC-NARROW A61P · 3 areas
- INNOV-THIN 28.2/100
- CLAIMS-PAR 9.8 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +300% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Guangdong Midea Electric Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Guangzhou’s 28.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Guangzhou
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Guangzhou Innocare… · this assignee 28
Guangzhou Innocare… · this assignee
28 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Guangzhou's Innovation Score is 28.2/100 (26th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Guangzhou?
Each dot is one of Guangzhou’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Guangzhou’s own 9.8 claims/patent is ABOVE the 6.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Guangzhou's grants concentrate
Guangzhou Innocare Pharma Tech Co., Ltd. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). By volume, Guangzhou sits between Guangdong Midea Electric Co., Ltd. and Guangzhou Pulisi Technology Co., Ltd..
Guangzhou's three-year grant acceleration
Guangzhou Innocare Pharma Tech Co., Ltd. shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Guangzhou's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Guangdong Midea E…
Guangdong Midea Electric Co., Ltd.
5 patents
- Guangdong Pharmac…
Guangdong Pharmaceutical University
5 patents
- Guangdong Power G…
Guangdong Power Grid Co Ltd.
5 patents
- Guangzhou Bizhuo…
Guangzhou Bizhuo Technology Co., Ltd.
5 patents
- Guangzhou Landsca…
Guangzhou Landscape Communication Equipment Co., Ltd.
5 patents
- Guangzhou Metro D…
Guangzhou Metro Design & Research Institute Co., Ltd.
5 patents
- Guangzhou Mokaqi…
Guangzhou Mokaqi Network Technology Co., Ltd.
5 patents
- Guangzhou Pulisi…
Guangzhou Pulisi Technology Co., Ltd.
5 patents
- Guangzhou Innocar… ◀
Guangzhou Innocare Pharma Tech Co., Ltd.
5 patents
What this shows Guangzhou holds 5 patents at rank #47,268, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Guangzhou
By rank, the assignees closest to #47,268 in granted patent volume.
- Guangdong Midea Electric Co., Ltd. #47,264 · 5 patents
- Guangdong Pharmaceutical University #47,265 · 5 patents
- Guangdong Power Grid Co Ltd. #47,266 · 5 patents
- Guangzhou Bizhuo Technology Co., Ltd. #47,267 · 5 patents
- Guangzhou Landscape Communication Equipment Co., Ltd. #47,269 · 5 patents
- Guangzhou Metro Design & Research Institute Co., Ltd. #47,270 · 5 patents
- Guangzhou Mokaqi Network Technology Co., Ltd. #47,271 · 5 patents
- Guangzhou Pulisi Technology Co., Ltd. #47,272 · 5 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Guangzhou's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Guangzhou's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
28 26th percentile higher than 26% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 1 | 20.0% |
| 2020 | 1 | 20.0% |
| 2022 | 1 | 20.0% |
| 2023 | 1 | 20.0% |
| 2024 | 1 | 20.0% |
Which technologies does Guangzhou Innocare Pharma Tech Co., Ltd. patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Guangzhou Innocare Pharma Tech Co., Ltd.'s patent record in context - here's where to go next.
- Guangzhou Innocare Pharma Tech Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #47,250 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Guangzhou Innocare Pharma Tech Co., Ltd. against Guangdong Midea Electric Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 28.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.